115 related articles for article (PubMed ID: 3490716)
1. [Various immunological and immunomorphological changes in patients with breast cancer after interferon administration].
Mkrtchian LN; Galstian AM; Ovanesbekova TG; Ter-Pogosian ZR; Kuznetsov VP
Vopr Onkol; 1986; 32(10):25-31. PubMed ID: 3490716
[TBL] [Abstract][Full Text] [Related]
2. [Modulating action of interferon preparations on cellular reactions of antitumor immunity].
Mkrtchian LN; Ter-Pogosian ZR; Sarkisian OM; Gevorkian RA; Movsesian EA
Vopr Onkol; 1983; 29(8):7-11. PubMed ID: 6351429
[TBL] [Abstract][Full Text] [Related]
3. [Morphological and immunologic changes following intratumoral administration of alpha interferon in patients with breast cancer].
Polevaia EB; Ermilova VD; Kupin VI
Vopr Onkol; 1986; 32(12):19-23. PubMed ID: 3492075
[TBL] [Abstract][Full Text] [Related]
4. [Immunomodulating effect of interferon after its intra-tumor administration in patients with breast cancer].
Polevaia EB; Kupin VI; Ermilova VD; Kuznetsov VP; Frolova IS
Sov Med; 1988; (2):23-6. PubMed ID: 3260405
[No Abstract] [Full Text] [Related]
5. [Stimulation of the immunological reactivity of cancer patients by Eleutherococcus extract].
Kupin VI; Polevaia EB
Vopr Onkol; 1986; 32(7):21-6. PubMed ID: 3526720
[TBL] [Abstract][Full Text] [Related]
6. [Functional activity of the regional lymph nodes in breast cancer patients].
Loboda VI; Grinevich IuA
Vopr Onkol; 1983; 29(2):31-6. PubMed ID: 6601329
[TBL] [Abstract][Full Text] [Related]
7. [Immunologic reactivity in patients with breast carcinoma treated with interferon alpha].
Stanojević-Bakić N; Vucković-Dekić Lj; Inić M; Tomin R
Glas Srp Akad Nauka Med; 1994; (44):71-82. PubMed ID: 7590417
[TBL] [Abstract][Full Text] [Related]
8. [Immunodiagnostic aspects of breast cancer. The phenomenon of leukocyte adherence inhibition].
Fritze D; Fritze J; Kaufmann M; Drings P
Minerva Med; 1978 Nov; 69(58):3963-7. PubMed ID: 740287
[TBL] [Abstract][Full Text] [Related]
9. [Micromodification of the leukocyte adherence inhibition test for cancer patients].
Kharkevich DD; Tabagari DZ; Savinov AIu
Vopr Onkol; 1985; 31(7):17-21. PubMed ID: 3895734
[TBL] [Abstract][Full Text] [Related]
10. [Mechanisms, kinetics and specificity of the leukocyte adherence inhibition test in breast cancer].
Kharkevich DD; Polevaia EB; Derevnina NA; Sablikova IuA; Savinov AIu
Eksp Onkol; 1985; 7(6):69-73. PubMed ID: 3910405
[TBL] [Abstract][Full Text] [Related]
11. [Cellular immunity in breast cancer patients].
Spielmann M; Kitschke HJ; Tietje K
Onkologie; 1982 Aug; 5 Suppl():42-5. PubMed ID: 6752790
[TBL] [Abstract][Full Text] [Related]
12. Augmented immunity in cancer patients treated with alpha-interferon.
Neefe JR; Sullivan JE; Ayoob M; Phillips E; Smith FP
Cancer Res; 1985 Feb; 45(2):874-8. PubMed ID: 3967248
[TBL] [Abstract][Full Text] [Related]
13. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
Tsang PH; Holland JF; Bekesi JG
J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
[TBL] [Abstract][Full Text] [Related]
14. Requirement for autologous cancer extracts and lipoxygenation of arachidonic acid for human T-cell responses in leukocyte adherence inhibition and transmembrane potential change assays.
Shenouda G; Thomson DM; MacFarlane JK
Cancer Res; 1984 Mar; 44(3):1238-45. PubMed ID: 6420056
[TBL] [Abstract][Full Text] [Related]
15. Detection of breast tumor antigen-sensitive circulating T-lymphocytes by antigen-stimulated active rosette formation.
Ramey WG; Hashim GA; Burrows WB; Swistel AJ; Munther A; Fitzpatrick HF
Cancer Res; 1979 Dec; 39(12):4796-801. PubMed ID: 315272
[No Abstract] [Full Text] [Related]
16. [The assessment of cellular immunity parameters in patients with breast cancer and lymphogranulomatosis during dynamic treatment].
Baldueva IA; Pukhova ZhK; Gavrilenkova LP; Mosberger ID
Vopr Onkol; 1992; 38(7):787-92. PubMed ID: 1300783
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancer.
Bishop MR; Fowler DH; Marchigiani D; Castro K; Kasten-Sportes C; Steinberg SM; Gea-Banacloche JC; Dean R; Chow CK; Carter C; Read EJ; Leitman S; Gress R
J Clin Oncol; 2004 Oct; 22(19):3886-92. PubMed ID: 15314059
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
Rentzsch C; Kayser S; Stumm S; Watermann I; Walter S; Stevanoviç S; Wallwiener D; Gückel B
Clin Cancer Res; 2003 Oct; 9(12):4376-86. PubMed ID: 14555509
[TBL] [Abstract][Full Text] [Related]
19. [Cellular immunity indices in benign breast tumors].
Baisheva SA; Zhalgasbaeva GT; Kaliev IuSh; Mezinova NN
Vopr Onkol; 1980; 26(5):15-9. PubMed ID: 7385708
[TBL] [Abstract][Full Text] [Related]
20. [Effect of immunomodifier on radiation-induced antitumor immunity following local irradiation to tumor--2. Mouse interferon-alpha/beta].
Mukae S; Norimura T; Tsuchiya T
Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Oct; 48(10):1243-8. PubMed ID: 3222138
[No Abstract] [Full Text] [Related]
[Next] [New Search]
